AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Present at Punk Ziegel Diabetes Symposium SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the Punk Ziegel & Company Diabetes Symposium on Wednesday, September 22, 2004 at 11:55 a.m. ET in New York. Dennis Kim, MD, Senior Director, Medical Affairs, of Amylin Pharmaceuticals, will be providing an overview of the exenatide development program. The live presentation will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate website, located at http://www.amylin.com/. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software. Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development and commercialization of innovative, cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals CONTACT: Mark G. Foletta, Vice President of Finance and Chief Financial Officer of Amylin Pharmaceuticals, +1-858-552-2200 Web site: http://www.amylin.com/

Copyright